Leukemia
NSAID use may be associated with risk of adult leukemia
Published in Clinical Oncology Week, August 18th, 2003
According to recent research from the United States, "Epidemiological studies have suggested that regular use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with reduced risk of some types of malignancy.
"Leukemia incidence and self-reported aspirin, as well as other NSAID use, were examined in a prospective cohort of >28,000 postmenopausal women. Eighty-one incident leukemia cases occurred during the period 1993-2000," wrote C.M. Kasum and colleagues, University of Minnesota Cancer Center.
"The multivariate-adjusted relative risk of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Adult Cancer
Psychosocial interventions improve quality of life in adult cancer patients - Colorectal Cancer
Study affirms safety of oxaliplatin for advanced disease - Endometrial Cancer
Study examines relation of possible prognostic indicators with clinical signs - Multiple Neoplasms
Older cancer patients may be at higher risk of developing second primaries - Pilocytic Astrocytoma
Protein can predict progression of most common childhood brain tumor - Advanced Cancer
Olanzapine may be used as antiemetic in refractory nausea/vomiting - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
